Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines

Molecular Pharmacology

Volumn 73, Issue 4, 2008, Pages 1235-1243

  Wunder, Frank ^a   Rebmann, Annegret ^a   Geerts, Andreas ^a   Kalthof, Bernd ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; AEQUORIN; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR 2; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; HEART; HUMAN; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS;

ADRENOMEDULLIN; ANIMALS; BLOOD VESSELS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KINETICS; MEMBRANE PROTEINS; MYOCARDIUM; PEPTIDE HORMONES; RECEPTORS, CALCITONIN; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RNA, MESSENGER;

EID: 41149100649     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.042283     Document Type: Article

References (39)

1. Aiyar N, Disa J, Pullen M, and Nambi P (2001) Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells. Mol Cell Biochem 224:123-133.
2. Altenhofen W, Ludwig J, Eismann E, Kraus W, Bönigk W, and Kaupp UB (1991) Control of ligand specificity in cyclic nucleotide-gated channels from rod photoreceptors and olfactory epithelium. Proc Natl Acad Sci U S A 88:9868-9872.
3. Aramori I and Nakanishi S (1992) Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 267:12468-12474.
4. Bailey RJ and Hay DL (2006) Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27:1367-1375.
5. Bönigk W, Bradley J, Muller F, Sesti F, Boekhoff I, Ronnett GV, Kaupp UB, and Frings S (1999) The native rat olfactory cyclic nucleotide-gated channel is composed of three distinct subunits. J Neurosci 19:5332-5347.
6. Bradley J, Li J, Davidson N, Lester HA, and Zinn K (1994) Heteromeric olfactory cyclic nucleotide-gated channels: a subunit that confers increased sensitivity to cAMP. Proc Natl Acad Sci U S A 91:8890-8894.
7. Brain SD and Grant AD (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903-934.
8. Burnstock G (2004) Introduction: P2 receptors. Curr Top Med Chem 4:793-803.
9. Champion HC, Nussdorfer GG, and Kadowitz PJ (1999) Structure-activity relationships of adrenomedullin in the circulation and adrenal gland. Regul Pept 85:1-8.
10. Conner AC, Simms J, Hay DL, Mahmoud K, Howitt SG, Wheatley M, and Poyner DR (2004) Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin. Biochem Soc Trans 32:843-846.
11. Doggrell SA (2001) Migraine and beyond: cardiovascular therapeutic potential for CGRP modulators. Expert Opin Investig Drugs 10:1131-1138.
12. Eguchi S, Hirata Y, Iwasaki H, Sato K, Watanabe TX, Inui T, Nakajima K, Sakakibara S, and Marumo F (1994) Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135:2454-2458.
13. Fagan KA, Schaack J, Zweifach A, and Cooper DM (2001) Adenovirus encoded cyclic nucleotide-gated channels: a new methodology for monitoring cAMP in living cells. FEBS Lett 500:85-90.
14. Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, and Vandecasteele G (2006) Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 99:816-828.
15. Ishimitsu T, Ono H, Minami J, and Matsuoka H (2006) Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther 111:909-927.
16. Jacoby E, Bouhelal R, Gerspacher M, and Seuwen K (2006) The 7 TM G-protein-coupled receptor target family. Chem Med Chem 1:761-782.
17. Kaupp UB and Seifert R (2002) Cyclic nucleotide-gated ion channels. Physiol Rev 82:769-824.
18. Kostenis E (2006) G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways. Curr Pharm Des 12:1703-1715.
19. Kurihara H, Shindo T, Oh-Hashi Y, Kurihar Y, and Kuwaki T (2003) Targeted disruption of adrenomedullin and alphaCGRP genes reveals their distinct biological roles. Hypertens Res 26:S105-S108.
20. Liman ER and Buck LB (1994) A second subunit of the olfactory cyclic nucleotidegated channel confers high sensitivity to cAMP. Neuron 13:611-621.
21. Liu M, Chen TY, Ahamed B, Li J, and Yau KW (1994) Calcium-calmodulin modulation of the olfactory cyclic nucleotide-gated cation channel. Science 266:1348-1354.
22. Liu J and Wess J (1996) Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. J Biol Chem 271:8772-8778.
23. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339.
24. Muff R, Born W, and Fischer JA (1995) Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 133:17-20.
25. Muff R, Born W, Lutz TA, and Fischer JA (2004) Biological importance of the peptides of the calcitonin family as revealed by disruption and transfer of corresponding genes. Peptides 25:2027-2038.
26. Nikolaev VO, Bünemann M, Hein L, Hannawacker A, and Lohse MJ (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279:37215-37218.
27. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, and Foord SM (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233-246.
28. Reinscheid RK, Kim J, Zeng J, and Civelli O (2003) High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotidegated channels. Eur J Pharmacol 478:27-34.
29. Rich TC, Fagan KA, Nakata H, Schaack J, Cooper DM, and Karpen JW (2000) Cyclic nucleotide-gated channels colocalize with adenylyl cyclase in regions of restricted cAMP diffusion. J Gen Physiol 116:147-161.
30. Rich TC, Tse TE, Rohan JG, Schaack J, and Karpen JW (2001) In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors. J Gen Physiol 118:63-78.
31. Roh J, Chang CL, Bhalla A, Klein C, and Hsu SY (2004) Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279:7264-7274.
32. Sautter A, Zong X, Hofmann F, and Biel M (1998) An isoform of the rod photoreceptor cyclic nucleotide-gated channel β subunit expressed in olfactory neurons. Proc Natl Acad Sci U S A 95:4696-4701.
33. Watanabe TX, Itahara Y, Inui T, Yoshizawa-Kumagaye K, Nakajima K, and Sakakibara S (1996) Vasopressor activities of N-terminal fragments of adrenomedullin in anesthetized rat. Biochem Biophys Res Commun 219:59-63.
34. Williams C (2004) cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Discov 3:125-135.
35. Wimalawansa SJ (1997) Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167-239.
36. Wunder F, Buehler G, Hüser J, Mundt S, Bechem M, and Kalthof B (2007) A cell-based nitric oxide reporter assay useful for the identification and characterization of modulators of the nitric oxide/guanosine 3′,5′-cyclic monophosphate pathway. Anal Biochem 363:219-227.
37. Wunder F, Stasch JP, Hütter J, Alonso-Alija C, Hüser J, and Lohrmann E (2005a) A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. Anal Biochem 339:104-112.
38. Wunder F, Tersteegen A, Rebmann A, Erb C, Fahrig T, and Hendrix M (2005b) Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line. Mol Pharmacol 68:1775-1781.
39. Zhang SP, Wang HY, Lovenberg TW, and Codd EE (2001) Functional studies of bradykinin receptors in Chinese hamster ovary cells stably expressing the human B2 bradykinin receptor. Int Immunopharmacol 1:955-965.